1. Personalized Medicine: Current and Future Perspectives Patricia Deverka, MD, MBe Duke University, Institute for Genome Sciences and Policy Rick J. Carlson, JD University…
Pharmacogenomics (PGx) in mental health Only 50% of patients with depression respond well to their initial antidepressant. For the remainder, a period of prolonged trial
Guideline on Evaluation of Anticancer Medicinal Products in ManGuideline on the evaluation of anticancer medicinal products in man Draft Agreed by Oncology Working Party
Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic ReviewPharmacogenetics and Pain Steroidal
PGPM_A_228709 59..70A Pharmacogenomic Dissection of a Rosuvastatin- Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions This article was published
Indicated association between polygenic risk score and treatment-resistance in a naturalistic sample of patients with schizophrenia spectrum disorders Maren Caroline Frogner